Topline data were announced from a phase 2/3 trial evaluating immune globulin intravenous (human) in patients with post-polio syndrome.
DelveInsight's "DARZALEX Market Size, Forecast, and Market Insight Report" highlights the details around DARZALEX, a human ...
The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...
The O-specific polysaccharide of Klebsiella pneumoniae in patients with bloodstream infections is immunogenic, and its closely related subtypes are cross-reactive.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback